Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
02/14/20234:07PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/14/20233:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/09/202310:49AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/08/202312:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/07/20234:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/07/20234:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/07/20234:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/06/20231:54PMEdgar (US Regulatory)Schedule 13g
(sc 13g/a)
NASDAQ:IMGNImmunoGen Inc
02/01/20233:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
01/04/20233:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
01/04/20233:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/04/20233:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/04/20233:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/04/20235:39AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
01/04/20235:30AMBusiness WireImmunoGen Appoints Michael Vasconcelles, MD, as Executive Vice President, Research, Development, and Medical AffairsNASDAQ:IMGNImmunoGen Inc
01/03/20234:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/20234:16PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
12/28/20223:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/28/20223:30PMBusiness WireImmunoGen Announces Susan Altschuller on FMLA Leave; Interim CFO AppointedNASDAQ:IMGNImmunoGen Inc
12/27/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/27/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/27/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/27/20223:31PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
12/27/20223:30PMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
12/10/20229:30AMBusiness WireImmunoGen Presents Findings from Expansion Cohorts in Phase 1b/2 Study of Pivekimab Sunirine with Vidaza® and Venclexta® in Acute Myeloid Leukemia at ASHNASDAQ:IMGNImmunoGen Inc
12/09/20227:56AMTipRanksImmunoGen Joins hands with Gilead on AML TherapyNASDAQ:IMGNImmunoGen Inc
12/09/20225:30AMBusiness WireImmunoGen Announces Clinical Collaboration with Gilead to Evaluate Pivekimab Sunirine in Combination with Magrolimab in Relapsed/Refractory Acute Myeloid LeukemiaNASDAQ:IMGNImmunoGen Inc
12/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
11/21/20225:30AMBusiness WireImmunoGen Appoints Daniel Char as Senior Vice President and Chief Legal OfficerNASDAQ:IMGNImmunoGen Inc
11/16/20221:56AMTipRanksSVB Securities Reaffirms Their Hold Rating on ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN